ASTRAZENECA A/S: Financial statements 2019
CVR: 55742928
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
ASTRAZENECA A/S (CVR 55742928) has filed annual accounts for 2019. In 2019, the company reported revenue of DKK 213,559,000 and a net result of DKK 6,271,000 compared with DKK 4,743,000 the year before. That is an increase of 46.8% compared with the year before. The profit margin was 2.9%. Equity in the 2019 report amounted to DKK 156,241,000. The solvency ratio was 73.9%. The company had 65 employees in the financial year.
- Revenue
- DKK 213,559,000
- Gross Profit
- DKK 94,173,000
- Profit/Loss
- DKK 6,271,000
- Equity
- DKK 156,241,000
- Total Assets
- DKK 211,527,000
- Employees
- 65
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | 213.6 mio. | 94.2 mio. | 6.3 mio. | 156.2 mio. | 65 |
| 2018 | 145.5 mio. | 85.4 mio. | 4.7 mio. | 150 mio. | 70 |
| 2017 | 167.7 mio. | 71.6 mio. | 5.5 mio. | 145.2 mio. | 77 |
| 2016 | 177.8 mio. | 68.8 mio. | 7.2 mio. | 139.8 mio. | 70 |
| 2015 | 171.2 mio. | 76 mio. | 2.5 mio. | 132.5 mio. | 77 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
ASTRAZENECA A/S has published its annual report for 2018. Revenue came to DKK 145,489,000, and the net result was DKK 4,743,000.
About ASTRAZENECA A/S
ASTRAZENECA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1943. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Christof Josef Bischoff. The board consists of Emelie Karin Susanne Antoni (chair), Charlotte Ivang Ladefoged, Christof Josef Bischoff and Erik Jesper Bergkvist. The company is owned by AstraZeneca Continent BV and AstraZeneca AB. The company has 71 employees (2018). In 2025, the company reported revenue of DKK 630,320,000 and a net result of DKK 24,203,000 compared with DKK 6,241,000 the year before. Equity in the 2025 report amounted to DKK 226,831,000.